AAD Issues 2nd Set of Choosing Wisely Recommendations

Share this content:
AAD Issues 2nd Set of <i>Choosing Wisely</i> Recommendations
AAD Issues 2nd Set of Choosing Wisely Recommendations

WEDNESDAY, Aug. 26, 2015 (HealthDay News) -- The American Academy of Dermatology (AAD) has published a second list of recommendations regarding dermatologic tests and treatments that are not always necessary.

A workgroup composed of board-certified dermatologists selected items with the greatest potential for overuse/misuse and a need for quality improvement. The recommendations were supported by strong evidence-based research.

The new AAD Choosing Wisely recommendations include: (1) not using systemic corticosteroids as a long-term treatment for dermatitis; (2) not using skin prick tests or blood tests for routine eczema evaluation; (3) not using microbiologic testing in the assessment and management of acne; (4) not routinely using antibiotics to treat bilateral swelling and redness of the lower leg, unless clear evidence of infection is seen; and (5) not routinely prescribing antibiotics for inflamed epidermal cysts.

"The American Academy of Dermatology and its members are committed to serving as good stewards of limited health care resources, and we want to empower our patients to make informed health care decisions," Mark Lebwohl, M.D., president of the Academy, said in a statement. "By identifying procedures that may not be necessary, the Academy's new Choosing Wisely list can help patients with skin, hair, and nail conditions start a conversation with their dermatologist about what tests and treatments are right for them."

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »